Heron Therapeutics (AXD2.F) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.05
-0.03
-0.01
0.02

Details

Expected EPS
-0.00549470115
Actual EPS
0.0088155
Surprise EPS
0.01
Surprise Percent
+260.44%

Description

⁨Heron Therapeutics⁩ (⁦AXD2.F⁩) has reported earnings of ⁦0.0088155⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts